Literature DB >> 34110400

Tracing the roots of CLPD-NK by TET2 and STAT3.

Marco Herling1, Till Braun1.   

Abstract

Entities:  

Keywords:  CHIP; NEOPLASIA/lymphomas and other lymphoproliferative conditions: genetic and other predisposing conditions; NK-cell; STAT3; TET2; clonality

Mesh：

Substances：

Year:  2021        PMID： 34110400      PMCID： PMC8351892          DOI： 10.1182/blood.2020010542

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Natural killer-cell differentiation by myeloid progenitors.

Authors:  Bartosz Grzywacz; Nandini Kataria; Niketa Kataria; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2010-12-20       Impact factor: 22.113

2.  Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.

Authors:  Philipp W Raess; Michael J Cascio; Guang Fan; Richard Press; Brian J Druker; Diana Brewer; Stephen E Spurgeon
Journal:  Am J Hematol       Date:  2016-11-18       Impact factor: 10.047

3.  High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.

Authors:  Enrico Tiacci; Alessandra Venanzi; Stefano Ascani; Andrea Marra; Valeria Cardinali; Giovanni Martino; Veronica Codoni; Gianluca Schiavoni; Maria Paola Martelli; Brunangelo Falini
Journal:  N Engl J Med       Date:  2018-09-06       Impact factor: 91.245

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

Authors:  Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Koskela; Francis Leblanc; Kwok Peng Ng; Thomas Olson; Bartlomiej Przychodzen; Manuel Afable; Ines Gomez-Segui; Kathryn Guinta; Lisa Durkin; Eric D Hsi; Kathy McGraw; Dan Zhang; Marcin W Wlodarski; Kimmo Porkka; Mikkael A Sekeres; Alan List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

6.  Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.

Authors:  Cédric Pastoret; Fabienne Desmots; Gaëlle Drillet; Simon Le Gallou; Marie-Laure Boulland; Alexia Thannberger; Anne-Violaine Doncker; Véronique Salaun; Gandhi Laurent Damaj; Richard Veyrat-Masson; Olivier Tournilhac; Aline Moignet; Céline Pangault; Mikaël Roussel; Thierry Fest; Thierry Lamy
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

7.  Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.

Authors:  P Savola; T Kelkka; H L Rajala; A Kuuliala; K Kuuliala; S Eldfors; P Ellonen; S Lagström; M Lepistö; T Hannunen; E I Andersson; R K Khajuria; T Jaatinen; R Koivuniemi; H Repo; J Saarela; K Porkka; M Leirisalo-Repo; S Mustjoki
Journal:  Nat Commun       Date:  2017-06-21       Impact factor: 14.919

8.  Clonal hematopoiesis in patients with rheumatoid arthritis.

Authors:  Paula Savola; Sofie Lundgren; Mikko A I Keränen; Henrikki Almusa; Pekka Ellonen; Marjatta Leirisalo-Repo; Tiina Kelkka; Satu Mustjoki
Journal:  Blood Cancer J       Date:  2018-07-26       Impact factor: 11.037

9.  A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.

Authors:  Vanessa Rebecca Gasparini; Andrea Binatti; Alessandro Coppe; Antonella Teramo; Cristina Vicenzetto; Giulia Calabretto; Gregorio Barilà; Annica Barizza; Edoardo Giussani; Monica Facco; Satu Mustjoki; Gianpietro Semenzato; Renato Zambello; Stefania Bortoluzzi
Journal:  Blood Cancer J       Date:  2020-04-22       Impact factor: 11.037

10.  Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.

Authors:  Johanne M Holst; Trine L Plesner; Martin B Pedersen; Henrik Frederiksen; Michael B Møller; Michael R Clausen; Marcus C Hansen; Stephen Jacques Hamilton-Dutoit; Peter Nørgaard; Preben Johansen; Tobias Ramm Eberlein; Bo K Mortensen; Gustav Mathiasen; Andreas Øvlisen; Rui Wang; Chao Wang; Weiwei Zhang; Hans Beier Ommen; Jesper Stentoft; Maja Ludvigsen; Wayne Tam; Wing C Chan; Giorgio Inghirami; Francesco d'Amore
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.